Dexiao Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dexiao Kong has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Chengyun Zheng
Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China
2 shared publications - Yang Jiang
Department of Hematology, The Second Qilu Hospital of Shandong University, Jinan, Shandong, China
2 shared publications Ai Li
1 shared publication- Ai Li
IIDepartment of Hematology, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
1 shared publication - Binggen Li
R&D Department Weihai Zhengsheng Biotechnology Co., Ltd Weihai China
1 shared publication - Chao Lai
VIDepartment of Neurology, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
1 shared publication
Latest Publications
- Open Access
- 20 August 2026
- Published by Elsevier in SSRN Electronic Journal
Integrated Single-cell and Bulk Transcriptomic Analyses Identify Megakaryocyte-erythroid Progenitor Cell Vulnerability and Erythroid Regulatory Decoupling in Severe Aplastic Anemia
Severe aplastic anemia (SAA) is a critical hematological disorder characterized by bone marrow hematopoietic failure and abnormal immune microenvironment. Longitudinal studies have emphasized the immune-mediated damage to hematopoietic stem/progenitor cells (HSPC), yet the differences in cell response, particularly the underlying programs of megakaryocyte-erythroid progenitor cells (MEP) in bone marrow microenvironment (BME) remain poorly understood. Herein, we constructed single-cell atlas by integrating scRNA-seq data of bone marrow mononuclear cells (BM-MNCs) in healthy control (Ctrl), non-SAA and SAA. Milo and Augur were respectively used for evaluating the changes in the abundance of disease-related cell states and ranking the sensitivity of cell type disease responses. Subsequently, independent bulk RNA-seq data were used for GSEA verification and WGCNA co-expression network analysis of MEP signatures. Cell-to-cell communication alterations were inferred through CellChat, while HSC/MPP-MEP-Ery differentiation trajectories, fate probabilities and regulatory module remodeling were evaluated by combining Monocle3, CellRank, impairment score and SCENIC/pySCENIC. Generally, a total of 18 sub-clusters in BM-MNCs were identified, and MEP was a highly disturbed progenitor cell in SAA with the highest Augur AUC score (0.852). SAA-MEP exhibited enhanced stress and mitochondrial respiration-related programs, while ribosome generation and protein translation-related processes were downregulated. The SAA-MEP signature was associated with immune activation, antigen presentation, protein degradation, and apoptosis-related modules enhancement. Meanwhile, abnormal HSC/MPP-MEP-Ery differentiation trajectories were observed in SAA. In details, the translation/rubisynthesis programs related to erythroid fate in SAA exhibited a loss of correlation, while DNA replication, RNA splicing, and chromosome maintenance-related programs were enhanced. Overall, these data revealed the multifaceted variations in the BME remodeling of SAA and the abnormal erythroid differentiation of MEP, which indicated the vulnerable state of MEP influenced by both the alteration of exogenous communication signals and the remodeling of intrinsic regulatory programs. Taken together, this study provides novel basis for understanding erythroid hematopoietic failure in SAA.
- 20 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntegrated Single-cell and Bulk Transcriptomic Analyses Identify Megakaryocyte-erythroid Progenitor Cell Vulnerability and Erythroid Regulatory Decoupling in Severe Aplastic Anemia
Severe aplastic anemia (SAA) is a critical hematological disorder characterized by bone marrow hematopoietic failure and abnormal immune microenvironment. Longitudinal studies have emphasized the immune-mediated damage to hematopoietic stem/progenitor cells (HSPC), yet the differences in cell response, particularly the underlying programs of megakaryocyte-erythroid progenitor cells (MEP) in bone marrow microenvironment (BME) remain poorly understood. Herein, we constructed single-cell atlas by integrating scRNA-seq data of bone marrow mononuclear cells (BM-MNCs) in healthy control (Ctrl), non-SAA and SAA. Milo and Augur were respectively used for evaluating the changes in the abundance of disease-related cell states and ranking the sensitivity of cell type disease responses. Subsequently, independent bulk RNA-seq data were used for GSEA verification and WGCNA co-expression network analysis of MEP signatures. Cell-to-cell communication alterations were inferred through CellChat, while HSC/MPP-MEP-Ery differentiation trajectories, fate probabilities and regulatory module remodeling were evaluated by combining Monocle3, CellRank, impairment score and SCENIC/pySCENIC. Generally, a total of 18 sub-clusters in BM-MNCs were identified, and MEP was a highly disturbed progenitor cell in SAA with the highest Augur AUC score (0.852). SAA-MEP exhibited enhanced stress and mitochondrial respiration-related programs, while ribosome generation and protein translation-related processes were downregulated. The SAA-MEP signature was associated with immune activation, antigen presentation, protein degradation, and apoptosis-related modules enhancement. Meanwhile, abnormal HSC/MPP-MEP-Ery differentiation trajectories were observed in SAA. In details, the translation/rubisynthesis programs related to erythroid fate in SAA exhibited a loss of correlation, while DNA replication, RNA splicing, and chromosome maintenance-related programs were enhanced. Overall, these data revealed the multifaceted variations in the BME remodeling of SAA and the abnormal erythroid differentiation of MEP, which indicated the vulnerable state of MEP influenced by both the alteration of exogenous communication signals and the remodeling of intrinsic regulatory programs. Taken together, this study provides novel basis for understanding erythroid hematopoietic failure in SAA.
- Open Access
Therapeutic outcomes of TP53-mutated diffuse large B cell lymphoma: A systematic review and meta-analysis
- 27 August 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (16) , e70024
PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells
The role of programmed cell death 4 (PDCD4) in multiple myeloma (MM) development remains unknown. Here, we investigated its role and action mechanism in MM. Bioinformatic analysis indicated that patients with MM and high PDCD4 expression had higher overall survival than those with low PDCD4 expression. PDCD4 expression promoted MM cell apoptosis and inhibited their viability in vitro and tumor growth in vivo. RNA‐binding protein immunoprecipitation sequencing analysis showed that PDCD4 is bound to the 5′ UTR of the apoptosis‐related genes PIK3CB , Cathepsin Z ( CTSZ ), and X‐chromosome‐linked apoptosis inhibitor ( XIAP ). PDCD4 knockdown reduced the cell apoptosis rate, which was rescued by adding PIK3CB, CTSZ, or XIAP inhibitors. Dual luciferase reporter assays confirmed the internal ribosome entry site (IRES) activity of the 5′ UTRs of PIK3CB and CTSZ . An RNA pull‐down assay confirmed binding of the 5′ UTR of PIK3CB and CTSZ to PDCD4, identifying the specific binding fragments. PDCD4 is expected to promote MM cell apoptosis by binding to the IRES domain in the 5′ UTR of PIK3CB and CTSZ and inhibiting their translation. Our findings suggest that PDCD4 plays an important role in MM development by regulating the expression of P IK3CB , CTSZ, and XIAP , and highlight new potential molecular targets for MM treatment.
- 27 August 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (16) , e70024
PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells
The role of programmed cell death 4 (PDCD4) in multiple myeloma (MM) development remains unknown. Here, we investigated its role and action mechanism in MM. Bioinformatic analysis indicated that patients with MM and high PDCD4 expression had higher overall survival than those with low PDCD4 expression. PDCD4 expression promoted MM cell apoptosis and inhibited their viability in vitro and tumor growth in vivo. RNA‐binding protein immunoprecipitation sequencing analysis showed that PDCD4 is bound to the 5′ UTR of the apoptosis‐related genes PIK3CB , Cathepsin Z ( CTSZ ), and X‐chromosome‐linked apoptosis inhibitor ( XIAP ). PDCD4 knockdown reduced the cell apoptosis rate, which was rescued by adding PIK3CB, CTSZ, or XIAP inhibitors. Dual luciferase reporter assays confirmed the internal ribosome entry site (IRES) activity of the 5′ UTRs of PIK3CB and CTSZ . An RNA pull‐down assay confirmed binding of the 5′ UTR of PIK3CB and CTSZ to PDCD4, identifying the specific binding fragments. PDCD4 is expected to promote MM cell apoptosis by binding to the IRES domain in the 5′ UTR of PIK3CB and CTSZ and inhibiting their translation. Our findings suggest that PDCD4 plays an important role in MM development by regulating the expression of P IK3CB , CTSZ, and XIAP , and highlight new potential molecular targets for MM treatment.
- Open Access
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
The coronavirus disease (COVID-19) outbreak has catastrophically threatened public health worldwide and presented great challenges for clinicians. To date, no specific drugs are available against severe acute respiratory syndrome coronavirus 2. Mesenchymal ...
Open AccessEfficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
The coronavirus disease (COVID-19) outbreak has catastrophically threatened public health worldwide and presented great challenges for clinicians. To date, no specific drugs are available against severe acute respiratory syndrome coronavirus 2. Mesenchymal ...